VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q4 2021. The put-call ratio across all filers is 1.44 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,930,000 | -65.6% | 80,000 | -58.0% | 0.76% | -76.4% |
Q3 2021 | $5,607,000 | -96.0% | 190,261 | -95.4% | 3.21% | -72.8% |
Q2 2021 | $141,784,000 | +564.5% | 4,172,561 | +535.6% | 11.78% | +335.5% |
Q1 2021 | $21,337,000 | -70.6% | 656,490 | -67.4% | 2.70% | -63.3% |
Q4 2020 | $72,470,000 | +16.2% | 2,011,912 | +26.3% | 7.38% | +4.1% |
Q3 2020 | $62,382,000 | +689.6% | 1,592,996 | +639.7% | 7.08% | +867.9% |
Q2 2020 | $7,900,000 | +5.0% | 215,367 | -34.1% | 0.73% | -52.7% |
Q1 2020 | $7,526,000 | +42.4% | 326,659 | +30.4% | 1.55% | +51.7% |
Q4 2018 | $5,284,000 | +9.5% | 250,509 | -3.8% | 1.02% | +173.5% |
Q3 2018 | $4,825,000 | -56.0% | 260,509 | -47.0% | 0.37% | -58.3% |
Q2 2018 | $10,974,000 | +207.6% | 491,869 | +206.9% | 0.90% | +61.6% |
Q1 2018 | $3,568,000 | – | 160,269 | – | 0.55% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hollow Brook Wealth Management LLC | 711,589 | $25,631,000 | 15.27% |
Sloane Robinson LLP | 450,000 | $16,209,000 | 15.04% |
New Harbor Financial Group, LLC | 1,103,389 | $39,744,000 | 14.30% |
Brown University | 541,096 | $19,490,000 | 14.10% |
Grand Central Investment Group | 426,777 | $15,373,000 | 13.75% |
New Harbor Financial Group, LLC | 1,055,400 | $38,015,000 | 13.68% |
Memorial Sloan Kettering Cancer Center | 738,500 | $26,601,000 | 11.26% |
Brevan Howard Capital Management LP | 1,420,000 | $51,148,000 | 10.26% |
Nokomis Capital, L.L.C. | 603,528 | $21,739,000 | 9.52% |
tru Independence LLC | 139,120 | $5,011,102,000 | 9.10% |